drugset
drugset / Trial / NCT03952507

A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants

NCT03952507 ↗

Phase 1 Completed 18 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The main purpose of this study is to evaluate the relative bioavailability of JNJ-64417184, formulated as a test formulation (tablet) compared to a reference formulation (suspension), administered orally in a fasted state, in healthy participants.

Timeline

Start
2019-05-15
Primary completion
2019-06-22
Completion
2019-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64417184 Unknown 600 mg Oral

Indications

No indication recorded.